5–9 de octubre de 2026
America/Asuncion zona horaria
Programa Completo del Evento disponible

Sesión

Neurociencia matemática – Oncología matemática

ST4
5 oct 2026, 14:30

Descripción

Modelos de Hodgkin-Huxley y de integración y disparo; redes neuronales biológicas y plasticidad sináptica; codificación neural y procesamiento sensorial; dinámica del crecimiento tumoral avascular y vascular; angiogénesis; invasión tisular y metástasis; heterogeneidad tumoral; modelos de radioterapia, quimioterapia e inmunoterapia; control óptimo de tratamientos; resistencia a drogas en cáncer; otros afines.

Materiales de la presentación

Todavía no hay materiales.

  1. Paulo Fernando de Arruda Mancera (UNESP)
    5/10/26, 14:30
    Neurociencia matemática – Oncología matemática
    Presentación Oral

    The term “cancer” encompasses a range of diseases characterized by uncontrolled cell proliferation and the potential to metastasize (National Cancer Institute (INCA), What Is Cancer?, Ministry of Health, 2023). Although widely used, traditional approaches such as chemotherapy, radiation therapy, and surgery face limitations, including systemic toxicity, low specificity, the development of...

    Go to contribution page
  2. Sr. Juan Daniel Huancas Gallardo (Universidad del Bío Bío)
    5/10/26, 14:50
    Neurociencia matemática – Oncología matemática
    Presentación Oral

    Chimeric Antigen Receptor T-cell therapy, known as CAR-T cell therapy,
    constitutes one of the most recent and innovative strategies in cancer
    immunotherapy. This therapy consists of genetically modifying a patient's own
    T lymphocytes so that they express chimeric receptors capable of recognizing
    specific antigens present on tumor cells. However, its long-term efficacy
    remains limited by...

    Go to contribution page
  3. Carola Gatica (Universidad del Bío Bío)
    5/10/26, 15:10
    Neurociencia matemática – Oncología matemática
    Presentación Oral

    In this work, we study a new three-dimensional mathematical model of cancer that describes the interaction between tumor cells, immune system effector cells, and the cytokine IL-2 in patients undergoing immunotherapy. The model accounts for both functional exhaustion and the depletion of effector cells, as well as their proliferation induced by tumor stimulation, thereby capturing relevant...

    Go to contribution page
Contruyendo el horario...